Showing results (291-300 of 364) with videos related to

Sort By:
Pageof 37
Blut|July 14, 1978
Oxymetholone treatment in myelofibrosisR Hast, L Engstedt, S Jameson, et al.
Scandinavian Journal of Haematology|February 1, 1976
Oxymetholone treatment in aregenerative anaemia. II. Remission and survival--a prospective studyR Hast, K O Skårberg, L Engstedt, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1985
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An updateD Machover, E Goldschmidt, L Schwarzenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?]G Mathé, J L Misset, D Machover, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogueG Mathé, P Pontiggia, S Orbach-Arbouys, et al.
Cancer Research|June 15, 1989
Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in miceN A Boughattas, F Lévi, C Fournier, et al.
Cancer Detection and Prevention|January 1, 1986
Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatmentJ L Misset, G Mathé, G Santelli, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1985
Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatmentJ L Misset, G Mathé, G Santelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in miceN A Boughattas, F Lévi, C Fournier, et al.
Cancer Letters|December 1, 1984
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observationsG Lemaigre, R Maral, C Bourut, et al.
Pageof 37